Vivani’s emerging pipeline also includes NPM-119, which refers to the Company’s six-month, subdermal, GLP-1 (exenatide implant) under development for the treatment of type 2 diabetes. Development of a ...

Vivani’s emerging pipeline also includes NPM-119, which refers to the Company’s six-month, subdermal, GLP-1 (exenatide implant) under development for the treatment of type 2 diabetes. Development of a ...

Vivani's emerging pipeline also includes NPM-119, which refers to the Company's six-month, subdermal, GLP-1 (exenatide implant) under development for the treatment of type 2 diabetes. Development of a ...

"Currently, Medicare covers these drugs only under specific circumstances, such as for diabetes or heightened heart risk," he wrote. "And Medicaid coverage is even more limited." Fetterman added ...

Gymnema is a complementary treatment for type 1 and type 2 diabetes. While it isn’t a replacement for insulin, it may aid in blood sugar regulation. Gymnema is a woody climbing shrub from the ...

The use of drugs like Ozempic, Wegovy and Zepbound in people with type 1 diabetes has risen sharply over the past decade, a new study finds, even though there’s little information on the drugs ...

Now, a major study published in JAMA Neurology reveals that certain medications used to treat type 2 diabetes might offer significant protection against Alzheimer’s disease and other forms of ...

The scientists found that two medications significantly reduce the risk of developing dementia in life. A new study, published in JAMA Neurology, finds that people with type 2 diabetes who take ...

Image credit: mbbirdy/Getty Images. A new study investigates the relationship between specific diabetes drugs and dementia. They used data from more than 92,000 people with type 2 diabetes.